These symptoms are often insidious in onset and ... Adapted from Schilsky ML, Tavil AS. Wilson disease. In: Schiff's Diseases of the Liver. Philadelphia: Lippincott Williams and Wilkins; 2006: ...
The majority of patients with WD present with either predominantly hepatic or neuropsychiatric symptoms ... and can occur early or late in the disease course. Rarely, patients exhibit chorea ...
Meanwhile, it contends, Wilson disease patients have a very wide range of symptoms, so zeroing in on neurological symptoms only may not provide a complete picture of the drug's effects.
About Wilson Disease Wilson disease is a rare and progressive ... 1 Patients can develop a wide range of symptoms, including liver disease and/or psychiatric or neurological symptoms, such as ...
A Charleston woman was always short of breath and suffered from an undertreated heart problem. A new device at MUSC has her ...
Monopar Therapeutics has secured an exclusive global license from Alexion Pharmaceuticals to develop and commercialize ALXN-1840, a promising treatment for Wilson disease, following a successful ...
Boulder County health officials said people can catch tularemia through bites from infected insects, most commonly ticks and ...
In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials ...
Monopar Therapeutics is recovering a drug from the scrap heap of AstraZeneca’s rare disease pipeline. It has licensed ALXN-1840, a candidate for the treatment of Wilson disease that was ...
A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.
The agreement grants Monopar (MNPR) an exclusive worldwide license to ALXN-1840 (bis-choline tetrathiomolybdate), a drug candidate for Wilson disease developed by Alexion that has completed a ...
The focus was on Wilson disease. Dr. Robinson came to know the Wilson disease community well through his efforts. At the Wilson Disease Association’s request, he delivered the keynote address at ...